No
Title
Presenter
Prize Orals
Paul Brand Award Oral How effectively offload patients with diabetic foot at home? Jarmila Jirkovska, Czech Republic
Prize Oral 1 Reducing diabetes related amputations following introduction of validated commissioning criteria in one UK region Richard Paisey, United Kingdom
Prize Oral 2 Impact of below-the-ankle peripheral arterial disease on the outcomes of diabetic patients with ischemic foot ulcers Marco Meloni, Italy
Prize Oral 3 Recurrence of diabetic foot ulcers: 10-year follow-up analysis in Eurodiale subgroup Michal Dubsky, Czech Republic
Oral Abstracts
O1 Reporting the assessment of new diabetic foot presentations in specialist clinics across Europe: focus on patient perceptions and the possible impact on their management Raju Ahluwalia, United Kingdom
O2 Five year mortality following diabetic amputation has not changed over 14 years Satyan Rajbhandari, United Kingdom
O3 Comparison of long-term outcomes in diabetic patients with critical limb ischemia treated by autologous cell therapy, percutaneous angioplasty or conservative therapy Andrea Nemcova, Czech Republic
O4 Screening MDT, UnderPressure! Graham Nuttall, United Kingdom
O5 Negative Pressure Wound Therapy Effect in Diabetic Foot Ulcer May Be Mediated Through Differential Gene Expression Sebastian Borys, Poland
O6 5-year Follow-up of Patients with Diabetes on Haemodialysis Paula Gardiner, Ireland
O7 Diagnostic accuracy of 99mTc-HMPAO-labeled leucocyte scintigraphy for diabetic foot osteomyelitis in relation to foot part involved and imaging technique Stamata Georga, Greece
O8 What is the most reliable and accurate plain X-ray sign in the diagnosis of diabetic foot osteomyelitis? Francisco Javier Alvaro Afonso, Spain
O9 The Infected Diabetic Foot: The value of inflammatory biomarkers to diagnose diabetic foot osteomyelitis Javier La Fontaine, United States
O10 Age at amputation is strongly related to mortality during 10 years follow up Bernard Pac Soo, United Kingdom
O11 Major lower-extremity amputations in people with and without diabetes in Belgium, 2009-2013 Patrick Lauwers, Belgium
O12 Diabetic foot surgical treatment in elderly over 75 years Roberto da Ros, Italy
O13 The spread of foot infection and its impact on the outcomes of major amputations of lower extremities in diabetic patients Danguole Vaznaisiene, Lithuania
O14 Declining offloading rate in Belgian Recognized Diabetic Foot Clinics (RDFC): results from an audit-feedback quality improvement initiative. Isabelle Dumont, Belgium
O15 Careful selection of insole material stiffness can significantly improve pressure reduction in therapeutic footwear and orthoses Panagiotis Chatzistergos, United Kingdom
O16 Clinical efficacy of therapeutic footwear with a rigid rocker sole in the prevention of reulceration in patients with Diabetes mellitus and diabetic polineuropathy: a prospective and randomized clinical trial Mateo López Moral, Spain
O17 Neuromechanical differences between diabetic patients with and without ulcerated feet Roozbeh Naemi, United Kingdom
O18 Can people with diabetes reduce the muscular demands of walking through altering the leverage at the ankle? Milos Petrovic, United Kingdom
O19 Digital deformities assessment should be consider before a percutaneous flexor tenotomy for management diabetic foot ulcers on the toes Irene Sanz, Spain
O20 Analysis of the foot's morpho-functional characteristics that can predispose in the development of a Charcot's Diabetic- Neuropathic-Osteo-Arthropathy (DNOA) José Luis Lázaro, Spain
O21 Bone immunohistochemistry and levels of RANKL, osteoprotegerin and inflammatory cytokines in acute charcot foot Ioanna Eleftheriadou, Greece
O22 Foot structural changes after lateral column exostectomy in patients with Charcot foot Raúl Molines Barroso, Spain
O23 Temperature difference less than 2 degrees compared with the contralateral foot does not rule active Charcot osteoarthopathy: imaging is mandatory  Jody Lucas, United Kingdom
O24 Total contact casting is a safe treatment modality for acute Charcot osteoarthropathy and neuropathic ulceration and is not associated with increased incidence of deep vein thrombosis. Michelle Stafford, United Kingdom
O25 Adherence to guideline-recommended medical therapies in type 2 diabetic patients with chronic critical limb ischemia Alberto Coppelli, Italy
O26 Glycaemic variability as measured by the magnitude of visit to visit HbA1c concentrations over the 5 years prior to presentation is significantly associated with rate of wound healing in the diabetic foot Ketan Dhatariya, United Kingdom
O27 Diabetic foot ulcer recurrence prediction:a time-to-event analysis Matilde Monteiro-Soares, Portugal
O28 Incidence and predictors of recurrent and new diabetic foot ulcers Susanne Engberg, Denmark
O29 Does the time interval between podiatric review and intervention infuence recurrence of diabetes foot ulcers? Jo McCardle, United Kingdom
O30 Infrainguinal revascularization in diabetic patients in hemodialysis. What has changed? Duarte Rego, Portugal
O31 Alteration of skin blood flow in response to locally applied pressure in type 2 diabetic patients with foot ulcer Julien Vouillarmet, France
O32 Thermographic imaging for detection of peripheral arterial disease: a comparative study Alfred Gatt, Malta
O33 Should Calcaneal Ulcers Be Managed In a Class of Their Own? Dhruti Hirani, United Kingdom
O34 Hospitalised individuals with diabetic foot disease have high prevalence of cognitive and psychiatric comorbidities which are associated with poor clincial outcomes Amanda Jurgsensen-Rauch, United Kingdom
O35 Influence of peripheral nerve system on proliferation and migration of keratinocytes on site of ulceration  Ekaterina Artemova, Russian Federation
O36 The association of Endothelial Progenitor Cells with peripheral neuropathy in patients with type 2 diabetes mellitus  Ioanna Eleftheriadou, Greece
O37 The disconnect between the presence or absence of clinical diabeticfoot infection and positive bacterial cultures. Zoe Davies, United Kingdom
O38 Evaluation of SPECT/CT in patients with diabetic foot infections - a five year's experience Aka Freya, Belgium
Poster Abstracts
P1 The impact of vascular status on the outcome of patients treated with a minor amputation for their diabetic foot osteomyelitis: a retrospective observational study Nafeesah Shafiq, United Kingdom
P2 Investigation into the relationship between plantar pressure and skin hardness in people with diabetes David Allan, United Kingdom
P3 Smart socks monitoring skin temperature can predict plantar pressure changes Mamdouh El-nahas, Egypt
P4 The effect of shoe outsolestiffness on plantar pressure and patient satisfaction in patients with diabetes at high risk of foot ulceration.  Sicco Bus, Netherlands
P5 Efficacy of a pro-active screening for diabetic foot ulceration in the community autonomously performed by nurses Alberto Piaggesi, Italy
P6 Sixty percent reduction of ulcer area at 2 weeks can be a useful predictor of eventually diabetic foot ulcer healing by 12 weeks Timothy Jemmott, United Kingdom
P7 Time sequence of bone marrow edema Resolution in the active diabetic Charcot foot-a retrospective Study Sofia Antoniou, Germany
P8 Microsurgical Diabetic Foot Ulcer Reconstruction: The Most Functional Reconstruction Donghyuk Shin, Korea, Rep. of South
P9 Ischemia as a prognostic factor in the outcome of the patients admitted in a Diabetic Foot Unit. Jesus Alfayate-Garcia, Spain
P10 Comparison of three different isolation methods of cell therapy of critical limb ischemia in diabetic patients  Anna Pyšná, Czech Republic
P11 Effectivness and cost-effectiveness of orthotic intervention in diabetes: A systematic review Aoife Healy, United Kingdom
P12 Which rocker outsole design is most effective for diabetic patients? Roozbeh Naemi, United Kingdom
P13 Walking poles and upright posture stability in diabetic patients Piergiorgio Francia, Italy
P14 Сolony forming units (CFU) as a marker of effectiveness of VAC with/without ultrasound debridement (USD) Maksym Gorobeiko, Ukraine
P15 A negative bone culture may predict a lower incidence of major amputation in patients with the diabetic foot Veronika Woskova, Czech Republic
P16 Exploration of serial changes in the microbiome of diabetic foot ulcers Frances Game, United Kingdom
P17 The microbiome of the chronic diabetic foot ulcers Elena Komelyagina, Russian Federation
P18 Multidrug resistant bacteria: an increasing complication of diabetic foot Elisabetta Iacopi, Italy
P19 Multiresistant Bacteria: Analysis of Multidisciplinary consultation of the Diabetic Foot Unit Liliana Fonseca, Portugal
P20 Breakthrough in treatment of skin barrier defects in diabetic feet with new foam technology Maximilian Spraul, Germany
P21 Annual diabetic foot risk assessment: is it necessary? Daniela M. M. Mendes, Portugal
P22 The measurement of skin temperature in the examination of the foot within the Diabetic Foot Clinic Wegin Tang, United Kingdom
P23 Effect on HbA1c, diabetes related problems and wellbeing of proactive multidisciplinary care for people with diabetic foot complications and poorly regulated HbA1c Mette Glindorf, Denmark
P24 Diabetic foot in patients after transplantation and it´s association with risk factors including education, prevention and physical activity Eliška Vrátná, Czech Republic
P25 Prognosis of wound healing in diabetic foot patients Tatiana Zelenina, Russian Federation
P26 Is there a relationship between bone quality and fracture risk in patients with type 2 diabetes Tatiana Gracheva, Russian Federation
P27 The role of topical oxygen therapy in the treatment of diabetic foot ulceration Nia Jones, United Kingdom
P28 Diabetic foot ulcers caused by rat bite in Tanzania Zulfiqarali G. Abbas, Tanzania
P29 Does cognitive function impairment influence the foot protective behavior? Marina Khlopina, Russian Federation
P30 Reference range for tcpO2 measurement on plantar foot surface: a pilot study Oleg Udovichenko, Russian Federation
P31 Botulinum toxin therapy is effective for lower limb spastic of CLI not to undergo revascularization Yuta Terabe, Japan
P32 Utilization of criopreserved arterial homografts in the revascularization of the comlicated diabetic foot Laura Carrasco Cortijo, Spain
P33 Rapid Access to Vascular -A New Local Initiative For Diabetic Foot Patients With Peripheral Vascular Disease Paula Grannon, United Kingdom
P34 Pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus Anastasios Tentolouris, Greece
P35 Vascular rehabilitation as part of the therapeutic alghorithm of diabetic PAD Toscanella Fabrizia, Italy
P36 5-years old results of endovascular treatment in diabetic patients with critical limb ischemia Zera Abdulvapova, Russian Federation
P37 What Degree of Blood Supply and Infection Control is Needed to Treat Forefoot Diabetic Critical Ischemia with Foot Osteomyelitis? Miki Fujii, Japan
P38 Removable contact splints in patients with diabetic foot under postoperative care Vladimira Fejfarova, Czech Republic
P39 Enhanced Offloading for Diabetic Foot Ulcers with Bilateral PulseFlow Technology Hadi Rahemi, United States
P40 Current Guidelines on Diabetic Foot Screening: An Evaluation of the Recommendations Cynthia Formosa, Malta
P41 SMART-FOOT project: Screening, Measures, Assessment, Reaction and Timely referral of diabetic FOOT problems Frank Nobels, Belgium
P42 Diabetic foot care education - developing an innovative way of teaching professionals in Portugal Sílvia Da Silva, Portugal
P43 A training video on diabetes foot assessment: an effective and versatile resource for multidisciplinary teams Francesco Medici, United Kingdom
P44 Diabetic foot education program (DFEP): Opinion Survey on management of diabetic foot in Indian Clinical Setup  Ashok Das, India
P45 Care Planning for Diabetic Foot Ulcers - Will it make a difference? Layth Hendow, United Kingdom
P46 The Effect of the Multi-Disciplinary Team on Morbidity and Mortality in Patients with Diabetic Foot Disease Laura Watson, United Kingdom
P47 Toe-Flow model: 3 years experience of Diabetic Foot Unit Juan Pedro Sanchez Rios, Spain
P48 Quality and Safety of Podiatric Independent Prescribing: a local retrospective audit within a Diabetic Outpatient Foot Clinic Jacqueline Mildred, United Kingdom
P49 The Impact Of Route Of Admission On Hospital Length Of Stay For Patients With Emergency Diabetes Foot Complications Jennifer Tremlett, United Kingdom
P50 Is exostectomy for chronic mid-foot plantar ulcer in Charcot deformity a good choice to prevent future events? Esther Garcia   Morales, Spain
P51 Plantar foot pressures, footwear adherence and ulcer recurrence in diabetic patients with Charcot foot deformity Renske Keukenkamp, Netherlands
P52 Epidemiology and early management of acute Charcot foot in a tertiary diabetic foot clinic in Belgium Severien Meyers, Belgium
P53 Charcot Neuroarthropathy (CN):factors characterizing a study population in Tuscany 2008-2015 Roberto Anichini, Italy
P54 Long-term effects of a diabetic Charcot foot on the progress of neuropathy Rasmus Jansen, Denmark
P55 Treatment of active Charcot neuropathic osteoatropathy by multidisciplinary diabetic foot team in hospital: Results of our six year´s experince Johana Venerová, Czech Republic
P56 Sudomotor examination should be regularly performed in patients with chronic kidney disease from predialysis stage (CKD4) but also after transplantation to detect nerve regeneration Dragan Tesic, Serbia
P57 Assesment of pain sensitivity and speed of wound healing in rats with streptozotocin-induced diabetes mellitus Anna Gorbacheva, Russian Federation
P58 The portable device for automated sural nerve conduction study: Utility for the diagnosis of peripheral neuropathy in patients with type 1 diabetes mellitus Nikolaos Papanas, Greece
P59 Diabetic foot experiences at Augusta Victoria Hospital within the context of low resource countries Reena abu Sneinah Reena, Palestine
P61 Peripheral neuropathy and lumbar spinal stenosis in patients with diabetes Katia Langton, Canada
P62 Early prediction of diabetic foot ulcer recurrence at Assiut , Egypt Walaa Khalifa, Egypt
P63 What is different about the diabetic patients with neuropathy compared to their non-neuropathic counterparts: A neuromechanical perspective  Nachiappan Chockalingham, United Kingdom
P64 An assessment of diabetes foot risk among T2DM patients in Kenya James  Ngoyo, Kenya
P65 Implementation of a joint diabetes renal microbiology multidisciplinary team in patients with diabetic foot disease receiving dialysis Joanne Casey, United Kingdom
P66 Longterm follow-up of a cohort with a history of diabetic foot ulcer in Austria Marlene Pandis, Austria
P67 Only 23% of diabetic foot infections needing acute hospital admission could be classified as severe based on current guidelines on temperature, pulse, respiration and white blood cell count Elizabeth Pendry, United Kingdom
P68 What is the outcome of newly presenting diabetic ischaemic foot ulcers at 6 months? Daina Walton, United Kingdom
P69 Sociodemographic and clinical characteristics of patients attending a first appointment at a Multidisciplinary Diabetic Foot Unit Teresa Pereira, Portugal
P70 Predictive parameters for lower limb amputations in a Diabetes Center in Romania George Nita, Romania
P71 Screening procedure and stratification of type 2 diabetic patients member of indonesian diabetes society as a reference for the prevention of diabetic foot complications Eva Niamuzisilawati, Indonesia
P72 Analysis of deleterius quality of life on caregivers of patients with diabetic foot ulcers Yolanda García Álvarez, Spain
P73 Gut is my home.. but I can be in toes too. A case of non healing osteomyelitis Kaustubh Nisal, United Kingdom
P74 Inflammatory markers have predictive value on the outcome of Diabetic Foot Osteomyelitis Aroa Tardáguila García, Spain
P75 The Total Contact Cast is successful in healing not only non-infected diabetic foot ulcers but also infected ulcers Nicole Mottolini, United Kingdom
P76 Challenges faced in managing diabetic foot infection caused by multidrug resistant gram negative organism in outpatient settings Fadwa Elsanousi, United Kingdom
P77 Haematological Effects of Linezolid: A Survey of Our Patient Experience Shailesh Gohil, United Kingdom
P78 Fungal osteomyeltis in the diabetic foot Venugopal Vimal, United Kingdom
P79 Influence of poor metabolic control in worseing presentation of Diabetic Foot Osteomyelitis Rebeca Alvarez-Madroñal, Spain
P80 Diabetic foot osteomyelitis: medical versus surgical approach Ana Amado, Portugal
P81 Risk factors for amputation in moderate and severe diabetic foot infection Ana Lopes, Portugal
P82 Improving home IV antibiotic therapy for diabetic foot patients Michael Pierides, United Kingdom
P83 Does assessment and management for QTc prolongation on 12-lead ECGin the diabetes foot clinic reduce mortality? Jonathan Valabhji, United Kingdom
P84 Syme amputation: a limb saving alternative with preservation of mobility in a middle-aged population with limited impaired bloodflow Pieter-Jan  Verfaillie, Belgium
P85 Gender difference in Diabetic Foot Ulcer Cesare Miranda, Italy
P86 Neuroischemic diabetic foot and rheopheresis treatment - a pilot study Pavlina Pithova, Czech Republic
P87 Investigation of factors related to Elevated Protease Activity (EPA) in patients with Diabetic Foot Ulcers Fotini Lakopoulou, Greece
P88 The Impact of Topical Phenytoin Loaded Nanostructured Lipid Carriers in Healing of Neuropathic Diabetic Foot Ulceration Mohamad Motawea, Egypt
P89 The use of sodic-salt DNA fragments in the progression of wound healing in diabetic foot. A case-control study Enrico Brocco, Italy
P90 Local application of human mesenchymal stromal cells accelerated wound healing in diabetic porcine model Robert Bem, Czech Republic
P91 Immunological perspectives of LeucoPatch treatment of Diabetic Foot Ulcers Jonas Damgård Schmidt, Denmark
P92 The relation between (day-to-day changes in) left-to-right differences in cumulative plantar tissue stress and plantar foot tempereature at high-risk locations in diabetes patients  Wouter aan de Stegge, Netherlands
P93 Tarsal Tunnel Sparing Incision - For the foot salvage surgery in the complicated diabetic foot and ankle infections Senthil Govindan, India
P94 Effects of different types of local treatment of foot ulcers in daibetic patients in comparison to standard management Gagik Galstyan, Russian Federation
P95 Non-suture technique utilizing negative pressure wound therapy for ischemic foot Shinobu Ayabe, Japan
P96 A calcium sulphate / hydroxyapatite bone graft substitute eluting gentamicin in the treatment of diabetic foot osteomyelitis: a mid-term follow-up Christine  Whisstock, Italy
P97 Reconstructive Surgery in Patients with Infectious Complications of Neuropathic Diabetic Foot Vladimir Obolenskiy, Russian Federation
P98 Domiciliary delivery of negative pressure wound therapy (NPWT) in diabetic foot patients after surgical procedures compared with in-hospital management: results of one year of follow up Chiara Goretti, Italy
P99 Sequestrectomy role in diabetic foot treatment Sokol Hasho, Albania
P100 External Fixation Types and Their Suitability for Various Diabetic Foot Reconstruction Operations Kamil Navratil, Czech Republic
P101 Arthroplasty with external fixation as a better option that arthroplasty without fixation to prevent long-term complications in patients affected by osteomyelitis Ana Pilar Ortiz Fernández , Spain
P102 The MDT Approach to the Diabetic Ankle Fracture: The importance of Targeting Glycaemic Control Post Surgery  Raju  Ahluwalia, United Kingdom